Desmosomes and Extradesmosomal Adhesive Signaling Contacts in Pemphigus

Medicinal Research Reviews

Volumn 34, Issue 6, 2014, Pages 1127-1145

  Waschke, Jens ^a   Spindler, Volker ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoantibodies; Cell adhesion; Desmogleins; Desmosomes; Pemphigus; Steric hindrance

Indexed keywords

ARMADILLO DOMAIN PROTEIN; AUTOANTIBODY; DESMOGLEIN 3; DESMOSOMAL CADHERIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PLAKIN; PROTEIN KINASE C; CADHERIN;

ARTICLE; CELL ADHESION; CELL CONTACT; CELL LOSS; CELL MATURATION; DESMOSOME; EXTRADESMOSOMAL ADHESIVE SIGNALING CONTACT; HUMAN; INTRACELLULAR SIGNALING; KERATINOCYTE; NONHUMAN; PATHOGENESIS; PEMPHIGUS; PROTEIN BINDING; PROTEIN FAMILY; REGULATORY MECHANISM; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

AUTOANTIBODIES; CADHERINS; CELL ADHESION; DESMOSOMES; HUMANS; PEMPHIGUS; SIGNAL TRANSDUCTION;

EID: 84907971653     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.21310     Document Type: Article

References (138)

1. Thomason HA, Scothern A, McHarg S, Garrod DR. Desmosomes: Adhesive strength and signalling in health and disease. Biochem J 2010;429(3):419-433.
2. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963;17(2):375-412.
3. Desai BV, Harmon RM, Green KJ. Desmosomes at a glance. J Cell Sci 2009;122(24):4401-4407.
4. Delva E, Tucker DK, Kowalczyk AP. The desmosome. Cold Spring Harb Perspect Biol 2009;1:a002543.
5. Dubash AD, Green KJ. Desmosomes. Curr Biol 2011;21(14):R529-R531.
6. Brooke MA, Nitoiu D, Kelsell DP. Cell-cell connectivity: Desmosomes and disease. J Pathol 2012;226(2):158-171.
7. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD. Perp is a p63-regulated gene essential for epithelial integrity. Cell 2005;120(6):843-856.
8. Franke W, Heid H, Zimbelmann R, Kuhn C, Winter-Simanowski S, Dörflinger Y, Grund C, Rickelt S. Transmembrane protein PERP is a component of tessellate junctions and of other junctional and non-junctional plasma membrane regions in diverse epithelial and epithelium-derived cells. Cell Tissue Res 2013;353(1):99-115.
9. Tsang SM, Brown L, Lin K, Liu L, Piper K, O'Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, Wan H. Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol 2012;227(1):81-93.
10. Müller EJ, Williamson L, Kolly C, Suter MM. Outside-in signaling through integrins and cadherins: A central mechanism to control epidermal growth and differentiation? J Invest Dermatol 2008;128(3):501-516.
11. Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol 2012;132(3):776-784.
12. Petrof G, Mellerio JE, McGrath JA. Desmosomal genodermatoses. Br J Dermatol 2012;166(1):36-45.
13. Delmar M, McKenna WJ. The cardiac desmosome and arrhythmogenic cardiomyopathies: From gene to disease. Circ Res 2010;107(6):700-714.
14. Basso C, Bauce B, Corrado D, Thiene G. Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 2012;9(4):223-233.
15. Rickelt S, Pieperhoff S. Mutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: A reference thesaurus for arrhythmogenic cardiomyopathies and for Naxos and Carvajal diseases. Cell Tissue Res 2012;348(2):325-333.
16. Chidgey M, Dawson C. Desmosomes: A role in cancer? Br J Cancer 2007;96(12):1783-1787.
17. Chen J, Nekrasova OE, Patel DM, Klessner JL, Godsel LM, Koetsier JL, Amargo EV, Desai BV, Green KJ. The C-terminal unique region of desmoglein 2 inhibits its internalization via tail-tail interactions. J Cell Biol 2012;199(4):699-711.
18. Posy S, Shapiro L, Honig B. Sequence and structural determinants of strand swapping in cadherin domains: Do all cadherins bind through the same adhesive interface? J Mol Biol 2008;378(4):954-968.
19. Nie Z, Merritt A, Rouhi-Parkouhi M, Tabernero L, Garrod D. Membrane-impermeable cross-linking provides evidence for homophilic, isoform-specific binding of desmosomal cadherins in epithelial cells. J Biol Chem 2011;286(3):2143-2154.
20. Al-Amoudi A, Diez DC, Betts MJ, Frangakis AS. The molecular architecture of cadherins in native epidermal desmosomes. Nature 2007;450(7171):832-837.
21. He W, Cowin P, Stokes DL. Untangling desmosomal knots with electron tomography. Science 2003;302(5642):109-113.
22. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 2005;115(11):3157-3165.
23. Schlegel N, Meir M, Heupel W-M, Holthöfer B, Leube RE, Waschke J. Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2010;298(5):G774-G783.
24. Heupel WM, Zillikens D, Drenckhahn D, Waschke J. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 2008;181(3):1825-1834.
25. Spindler V, Heupel W-M, Efthymiadis A, Schmidt E, Eming R, Rankl C, Hinterdorfer P, Müller T, Drenckhahn D, Waschke J. Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus. J Biol Chem 2009;284(44):30556-30564.
26. Mahoney MG, Hu Y, Brennan D, Bazzi H, Christiano AM, Wahl JK, 3rd. Delineation of diversified desmoglein distribution in stratified squamous epithelia: Implications in diseases. Exp Dermatol 2006;15(2):101-109.
27. Hartlieb E, Kempf B, Partilla M, Vigh B, Spindler V, Waschke J. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. PLoS One 2013;8(1):e53739.
28. Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, Leube RE. Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells. Eur J Cell Biol 2002;81(11):592-598.
29. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley JR. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997;137(5):1091-1102.
30. Chen J, Den Z, Koch PJ. Loss of desmocollin 3 in mice leads to epidermal blistering. J Cell Sci 2008;121(17):2844-2849.
31. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103(4):461-468.
32. Nekrasova OE, Amargo EV, Smith WO, Chen J, Kreitzer GE, Green KJ. Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes. J Cell Biol 2011;195(7):1185-1203.
33. Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O'Brien T, Uitto J, Rodeck U, Mahoney MG. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 2007;120(5):758-771.
34. Waschke J, Menendez-Castro C, Bruggeman P, Koob R, Amagai M, Gruber HJ, Drenckhahn D, Baumgartner W. Imaging and force spectroscopy on desmoglein 1 using atomic force microscopy reveal multivalent Ca(2+)-dependent, low-affinity trans-interaction. J Membr Biol 2007;216(2-3):83-92.
35. Celli A, Sanchez S, Behne M, Hazlett T, Gratton E, Mauro T. The epidermal Ca(2+) gradient: Measurement using the phasor representation of fluorescent lifetime imaging. Biophys J 2010;98(5):911-921.
36. Getsios S, Simpson CL, Kojima S-i, Harmon R, Sheu LJ, Dusek RL, Cornwell M, Green KJ. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009;185(7):1243-1258.
37. Harmon RM, Simpson CL, Johnson JL, Koetsier JL, Dubash AD, Najor NA, Sarig O, Sprecher E, Green KJ. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. J Clin Invest 2013;123(4):1556-1570.
38. Acehan D, Petzold C, Gumper I, Sabatini DD, Muller EJ, Cowin P, Stokes DL. Plakoglobin is required for effective intermediate filament anchorage to desmosomes. J Invest Dermatol 2008;128(11):2665-2675.
39. Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, Kohlhase J, Hausser I, Bruckner-Tuderman L, Has C. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: A novel clinico-genetic entity. Hum Mol Genet 2011;20(9):1811-1819.
40. Simpson CL, Kojima S-i, Cooper-Whitehair V, Getsios S, Green KJ. Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: Implications for exfoliative toxin-mediated skin blistering. Am J Pathol 2010;177(6):2921-2937.
41. Ryan KR, Lock FE, Heath JK, Hotchin NA. Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3. J Cell Sci 2012;125(13):3202-3209.
42. Sylvie J, Ellen C, Kris V. The role of Wnt in cell signaling and cell adhesion during early vertebrate development. Front Biosci 2011;16:2352-2366.
43. Tokonzaba E, Chen J, Cheng X, Den Z, Ganeshan R, Muller EJ, Koch PJ. Plakoglobin as a regulator of desmocollin gene expression. J Invest Dermatol 2013;133:2732-2740.
44. Aktary Z, Pasdar M. Plakoglobin: Role in tumorigenesis and metastasis. Int J Cell Biol 2012;2012:189521.
45. Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, Marian AJ. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 2011;109(12):1342-1353.
46. Bass-Zubek AE, Godsel LM, Delmar M, Green KJ. Plakophilins: Multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 2009;21(5):708-716.
47. Sobolik-Delmaire T, Reddy R, Pashaj A, Roberts BJ, Wahl JK. Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J Invest Dermatol 2010;130(11):2638-2646.
48. + medium in DJM-1 cells. J Dermatol 2008;35(6):317-324.
49. Hobbs RP, Green KJ. Desmoplakin regulates desmosome hyperadhesion. J Invest Dermatol 2012;132(2):482-485.
50. Choi H-J, Weis WI. Crystal structure of a rigid four-spectrin-repeat fragment of the human desmoplakin plakin domain. J Mol Biol 2011;409(5):800-812.
51. Cabral RM, Tattersall D, Patel V, McPhail GD, Hatzimasoura E, Abrams DJ, South AP, Kelsell DP. The DSPII splice variant is crucial for desmosome-mediated adhesion in HaCaT keratinocytes. J Cell Sci 2012;125(12):2853-2861.
52. Löffek S, Bruckner-Tuderman L, Magin TM. Involvement of the ubiquitin-proteasome system in the stabilization of cell-cell contacts in human keratinocytes. Exp Dermatol 2012;21(10):791-793.
53. Mahoney MG, Muller EJ, Koch PJ. Desmosomes and desmosomal cadherin function in skin and heart diseases-Advancements in basic and clinical research. Dermatol Res Pract 2010; vol. 2010, Article ID 725647.
54. Sumigray KD, Lechler T. Desmoplakin controls microvilli length but not cell adhesion or keratin organization in the intestinal epithelium. Mol Biol Cell 2012;23(5):792-799.
55. Nachat R, Cipolat S, Sevilla LM, Chhatriwala M, Groot KR, Watt FM. KazrinE is a desmosome-associated liprin that colocalises with acetylated microtubules. J Cell Sci 2009;122(22):4035-4041.
56. Kröger C, Loschke F, Schwarz N, Windoffer R, Leube RE, Magin TM. Keratins control intercellular adhesion involving PKC-α-mediated desmoplakin phosphorylation. J Cell Biol 2013;201(5):681-692.
57. Pan X, Hobbs RP, Coulombe PA. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr Opin Cell Biol 2013;25(1):47-56.
58. Lewis JE, Wahl JK, Sass KM, Jensen PJ, Johnson KR, Wheelock MJ. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol 1997;136(4):919-934.
59. Michels C, Buchta T, Bloch W, Krieg T, Niessen CM. Classical cadherins regulate desmosome formation. J Invest Dermatol 2009;129(8):2072-2075.
60. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988;107(4):1575-1587.
61. Vasioukhin V, Bauer C, Yin M, Fuchs E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 2000;100(2):209-219.
62. Wahl JK. A role for plakophilin-1 in the initiation of desmosome assembly. J Cell Biochem 2005;96(2):390-403.
63. Demlehner MP, Schäfer S, Grund C, Franke WW. Continual assembly of half-desmosomal structures in the absence of cell contacts and their frustrated endocytosis: A coordinated Sisyphus cycle. J Cell Biol 1995;131(3):745-760.
64. Gosavi P, Kundu S, Khapare N, Sehgal L, Karkhanis M, Dalal S. E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly. Cell Mol Life Sci 2011;68(8):1439-1454.
65. Godsel LM, Hsieh SN, Amargo EV, Bass AE, Pascoe-McGillicuddy LT, Huen AC, Thorne ME, Gaudry CA, Park JK, Myung K, Goldman RD, Chew T-L, Green KJ. Desmoplakin assembly dynamics in four dimensions. J Cell Biol 2005;171(6):1045-1059.
66. Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK, Denning MF, Green KJ. Plakophilin 2: A critical scaffold for PKCα that regulates intercellular junction assembly. J Cell Biol 2008;181(4):605-613.
67. Godsel LM, Dubash AD, Bass-Zubek AE, Amargo EV, Klessner JL, Hobbs RP, Chen X, Green KJ. Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA. Mol Biol Cell 2010;21(16):2844-2859.
68. Resnik N, Sepčić K, Plemenitaš A, Windoffer R, Leube R, Veranič P. Desmosome assembly and cell-cell adhesion are membrane raft-dependent processes. J Biol Chem 2011;286(2):1499-1507.
69. Sato M, Aoyama Y, Kitajima Y. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 2000;80(10):1583-1592.
70. Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H. Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Exp Cell Res 2012;318(18):2269-2283.
71. Windoffer R, Borchert-Stuhltrager M, Leube RE. Desmosomes: interconnected calcium-dependent structures of remarkable stability with significant integral membrane protein turnover. J Cell Sci 2002;115(8):1717-1732.
72. Garrod D, Kimura TE. Hyper-adhesion: A new concept in cell-cell adhesion. Biochem Soc Trans 2008;36(Pt 2):195-201.
73. Kimura TE, Merritt AJ, Garrod DR. Calcium-independent desmosomes of keratinocytes are hyper-adhesive. J Invest Dermatol 2007;127(4):775-781.
74. Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D. The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell 2000;11(3):1077-1092.
75. Garrod DR, Berika MY, Bardsley WF, Holmes D, Tabernero L. Hyper-adhesion in desmosomes: Its regulation in wound healing and possible relationship to cadherin crystal structure. J Cell Sci 2005;118(Pt 24):5743-5754.
76. Kitajima Y. Regulation and impairments of dynamic desmosome and corneodesmosome remodeling. Eur J Dermatol 2013 Apr 30 [Epub ahead of print] in PubMED.
77. Aoyama Y, Kitajima Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 1999;112(1):67-71.
78. Tsang SM, Liu L, Teh M-T, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F, Wan H. Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PLoS One 2010;5(12):e14211.
79. Oliveira MEF, Culton DA, Prisayanh P, Qaqish BF, Diaz LA. E-cadherin autoantibody profile in patients with pemphigus vulgaris. Br J Dermatol 2013;169(4):812-818.
80. Evangelista F, Dasher DA, Diaz LA, Prisayanh PS, Li N. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol 2008;128(7):1710-1718.
81. Roh JY, Stanley JR. Intracellular domain of desmoglein 3 (pemphigus vulgaris antigen) confers adhesive function on the extracellular domain of E-cadherin without binding catenins. J Cell Biol 1995;128(5):939-947.
82. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D. Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 2006;175(5):721-727.
83. Gliem M, Heupel W-M, Spindler V, Harms GS, Waschke J. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. Am J Physiol Cell Physiol 2010;299(3):C606-C613.
84. Spindler V, Rotzer V, Dehner C, Kempf B, Gliem M, Radeva M, Hartlieb E, Harms GS, Schmidt E, Waschke J. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest 2013;123(2):800-811.
85. Brennan D, Peltonen S, Dowling A, Medhat W, Green KJ, Wahl JK, III, Del Galdo F, Mahoney MG. A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene 2012;31(13):1636-1648.
86. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, Green KJ, Parkos CA, Nusrat A. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 2007;18(11):4565-4578.
87. Mannan T, Jing S, Foroushania SH, Fortune F, Wan H. RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif 2011;44(4):301-310.
88. Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/{beta}-catenin signaling. Mol Biol Cell 2011;22(8):1121-1134.
89. Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, Payne AS. Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol 2010;177(6):2724-2730.
90. Rafei D, Müller R, Ishii N, Llamazares M, Hashimoto T, Hertl M, Eming R. IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion. Am J Pathol 2011;178(2):718-723.
91. Kalantari-Dehaghi M, Chen Y, Deng W, Chernyavsky A, Marchenko S, Wang PH, Grando SA. Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies. J Biol Chem 2013;288(23):16916-16925.
92. Grando S. Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity 2012;45(1):7-35.
93. Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One 2012;7(12):e50696.
94. Mao X, Sano Y, Park JM, Payne AS. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 2011;286(2):1283-1291.
95. Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne AS. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol 2013;134:68-76.
96. Schulze K, Galichet A, Sayar BS, Scothern A, Howald D, Zymann H, Siffert M, Zenhausern D, Bolli R, Koch PJ, Garrod D, Suter MM, Muller EJ. An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol 2012;132(2):346-355.
97. Wang W, Amagai M, Ishiko A. Desmosome splitting is a primary ultrastructural change in the acantholysis of pemphigus. J Dermatol Sci 2008;54:59-61.
98. Yamagami J, Payne AS, Kacir S, Ishii K, Siegel DL, Stanley JR. Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity. J Clin Invest 2010;120(11):4111-4117.
99. Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, Amagai M, Ishii K. Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009;129:2156-2166.
100. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T, Koyasu S, Nishikawa T, Amagai M. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003;170(4):2170-2178.
101. Heupel W-M, Müller T, Efthymiadis A, Schmidt E, Drenckhahn D, Waschke J. Peptides targeting the desmoglein 3 adhesive interface prevent autoantibody-induced acantholysis in pemphigus. J Biol Chem 2009;284(13):8589-8595.
102. Di Zenzo G, Di Lullo G, Corti D, Calabresi V, Sinistro A, Vanzetta F, Didona B, Cianchini G, Hertl M, Eming R, Amagai M, Ohyama B, Hashimoto T, Sloostra J, Sallusto F, Zambruno G, Lanzavecchia A. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J Clin Invest 2012;122(10):3781-3790.
103. Getsios S, Waschke J, Borradori L, Hertl M, Muller EJ. From cell signaling to novel therapeutic concepts: International pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol 2010;130(7):1764-1768.
104. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem 2005;280(25):23778-23784.
105. Kawasaki Y, Aoyama Y, Tsunoda K, Amagai M, Kitajima Y. Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line. Autoimmunity 2006;39(7):587-590.
106. Lee HE, Berkowitz P, Jolly PS, Diaz LA, Chua MP, Rubenstein DS. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J Biol Chem 2009;284(18):12524-12532.
107. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci USA 2006;103(34):12855-12860.
108. Berkowitz P, Chua M, Liu Z, Diaz LA, Rubenstein DS. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol 2008;173(6):1628-1636.
109. Berkowitz P, Diaz LA, Hall RP, Rubenstein DS. Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol 2007;128(3):738-740.
110. Mao X, Choi EJ, Payne AS. Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol 2009;129(4):908-918.
111. Bektas M, Jolly PS, Berkowitz P, Amagai M, Rubenstein DS. A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol Chem 2013;288(13):9447-9456.
112. Spindler V, Vielmuth F, Schmidt E, Rubenstein DS, Waschke J. Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies. J Immunol 2010;185(11):6831-6838.
113. Kölsch A, Windoffer R, Würflinger T, Aach T, Leube RE. The keratin-filament cycle of assembly and disassembly. J Cell Sci 2010;123(13):2266-2272.
114. Man Tsang S, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H. Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Exp Cell Res 2012;318(18):2269-2283.
115. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem 2008;283(26):18303-18313.
116. Jennings JM, Tucker DK, Kottke MD, Saito M, Delva E, Hanakawa Y, Amagai M, Kowalczyk AP. Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol 2011;131(3):706-718.
117. Nguyen B, Dusek RL, Beaudry VG, Marinkovich MP, Attardi LD. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies. J Invest Dermatol 2009;129(7):1710-1718.
118. Oktarina DAM, van der Wier G, Diercks GFH, Jonkman MF, Pas HH. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol 2011;165(3):552-562.
119. Aoyama Y, Nagai M, Kitajima Y. Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. Br J Dermatol 2010;162(5):1049-1055.
120. Kitajima Y. New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease. Kaohsiung J Med Sci 2013;29(1):1-13.
121. Cirillo N, Lanza A, Prime SS. Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res 2010;316(4):580-592.
122. Spindler V, Endlich A, Hartlieb E, Vielmuth F, Schmidt E, Waschke J. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: A role in suprabasal epidermal skin splitting? Am J Pathol 2011;179(4):1905-1916.
123. Waschke J. The desmosome and pemphigus. Histochem Cell Biol 2008;130(1):21-54.
124. Sánchez-Carpintero I, España A, Pelacho B, López Moratalla N, Rubenstein DS, Diaz LA, López-Zabalza MJ. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 2004;151(3):565-570.
125. Frusic-Zlotkin M, Raichenberg D, Wang X, David M, Michel B, Milner Y. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis-Possible involvement of the EGF receptor. Autoimmunity 2006;39(7):563-575.
126. Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: Characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem 2007;282(18):13804-13812.
127. Hata T, Nishifuji K, Shimoda K, Sasaki T, Yamada T, Nishikawa T, Koyasu S, Amagai M. Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris. J Dermatol Sci 2011;63(1):33-39.
128. Pretel M, España A, Marquina M, Beatriz Pelacho, López-Picazo J, López-Zabalza J. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp Dermatol 2009;18(9):771-780.
129. Gil MP, Modol T, España A, López-Zabalza MJ. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris. Exp Dermatol 2012;21(4):254-259.
130. España A, Mòdol T, Gil MP, López-Zabalza MJ. Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase. Exp Dermatol 2013;22(2):125-130.
131. Marquina M, España A, Fernández-Galar M, López-Zabalza MJ. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model. Br J Dermatol 2008;159(1):68-76.
132. Schmidt E, Waschke J. Apoptosis in pemphigus. Autoimmun Rev 2009;8(7):533-537.
133. Schmidt E, Gutberlet J, Siegmund D, Berg D, Wajant H, Waschke J. Apoptosis is not required for acantholysis in pemphigus vulgaris. Am J Physiol Cell Physiol 2009;296(1):C162-C172.
134. Cirillo N, Campisi G, Gombos F, Perillo L, Femiano F, Lanza A. Cleavage of desmoglein 3 can explain its depletion from keratinocytes in pemphigus vulgaris. Exp Dermatol 2008;17(10):858-863.
135. Li N, Zhao M, Wang J, Liu Z, Diaz LA. Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. J Immunol 2009;182(1):711-717.
136. Heupel W-M, Engerer P, Schmidt E, Waschke J. Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. Am J Pathol 2009;174(2):475-485.
137. Mao X, Sano Y, Park JM, Payne AS. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. J Biol Chem 2011;286(2):1283-1291.
138. Tsunoda K, Ota T, Saito M, Hata T, Shimizu A, Ishiko A, Yamada T, Nakagawa T, Kowalczyk AP, Amagai M. Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. Am J Pathol 2011;179(2):795-806.